about
Cholelithiasis in patients on the kidney transplant waiting listGender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.Curcuma longa L. as a therapeutic agent in intestinal motility disorders. 2: Safety profile in mouseBenefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.A population-based cohort study of symptomatic gallstone disease in diabetic patients.Updates in the treatment of gallstones.Laparoscopic cholecystectomy: consensus conference-based guidelines.
P2860
Q33822883-A76E3996-C394-4190-B350-2D05FCF517C6Q33997826-620187DA-916C-4793-8CE5-FF7ACD90EF2DQ35049360-9B5845A2-E665-4510-8710-67D9C169AA4EQ35225117-9F4337BF-6CE8-49B1-B3EF-5AEC2BA429B0Q35886694-9CF106DB-9DD3-4111-A895-B3F662B0BE4CQ37636102-C646E390-700F-499D-ABF4-79EA41C3A0C3Q38409865-CCFB6E36-E1BE-45C7-83AF-58FF5160955C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gallstone disease: Primary and secondary prevention.
@ast
Gallstone disease: Primary and secondary prevention.
@en
type
label
Gallstone disease: Primary and secondary prevention.
@ast
Gallstone disease: Primary and secondary prevention.
@en
prefLabel
Gallstone disease: Primary and secondary prevention.
@ast
Gallstone disease: Primary and secondary prevention.
@en
P1476
Gallstone disease: Primary and secondary prevention.
@en
P2093
Karel J van Erpecum
Niels G Venneman
P304
P356
10.1016/J.BPG.2006.03.008
P577
2006-01-01T00:00:00Z